JP2022525148A5 - - Google Patents
Info
- Publication number
- JP2022525148A5 JP2022525148A5 JP2021555221A JP2021555221A JP2022525148A5 JP 2022525148 A5 JP2022525148 A5 JP 2022525148A5 JP 2021555221 A JP2021555221 A JP 2021555221A JP 2021555221 A JP2021555221 A JP 2021555221A JP 2022525148 A5 JP2022525148 A5 JP 2022525148A5
- Authority
- JP
- Japan
- Prior art keywords
- compound
- pharmaceutical composition
- composition according
- cystamine
- cysteamine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962823892P | 2019-03-26 | 2019-03-26 | |
| US62/823,892 | 2019-03-26 | ||
| PCT/US2020/025067 WO2020198529A1 (en) | 2019-03-26 | 2020-03-26 | Substituted amino-thiol and amino-disulfide compounds, and uses thereof |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2022525148A JP2022525148A (ja) | 2022-05-11 |
| JP2022525148A5 true JP2022525148A5 (enExample) | 2023-03-16 |
| JP7538541B2 JP7538541B2 (ja) | 2024-08-22 |
Family
ID=72610131
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021555221A Active JP7538541B2 (ja) | 2019-03-26 | 2020-03-26 | 置換されたアミノチオール及びアミノジスルフィド化合物、及びそれらの使用 |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US12391643B2 (enExample) |
| EP (1) | EP3946298A4 (enExample) |
| JP (1) | JP7538541B2 (enExample) |
| CN (1) | CN113613642B (enExample) |
| WO (1) | WO2020198529A1 (enExample) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2021022012A1 (en) * | 2019-07-30 | 2021-02-04 | The Regents Of The University Of California | Methods and composition for treating respiratory obstructive diseases |
| CN115745857B (zh) * | 2022-10-28 | 2025-10-17 | 中国医学科学院放射医学研究所 | 一类口服给药的活性氧响应的硫酯类化合物、合成方法及用途 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5254730A (en) * | 1992-01-14 | 1993-10-19 | Kilgore James L | Production of amino acids and amino acid derivatives bearing isotopic hydrogen labels |
| PT1919458E (pt) | 2006-01-27 | 2012-08-23 | Univ California | Cisteamina revestida entericamente, cisteamina e seus derivados |
| US7750168B2 (en) * | 2006-02-10 | 2010-07-06 | Sigma-Aldrich Co. | Stabilized deuteroborane-tetrahydrofuran complex |
| HRP20130590T1 (en) | 2007-11-30 | 2013-08-31 | The Regents Of The University Of California | Methods of treating non-alcoholic steatohepatitis (nash) using cysteamine products |
| US8530479B2 (en) * | 2009-08-10 | 2013-09-10 | Daljit Singh Dhanoa | Deuterium-enriched alkyl sulfonamides |
| CA2732440C (en) * | 2011-02-23 | 2017-10-31 | Universite Laval | Cystamine analogues for the treatment of parkinson`s disease |
| TW201618760A (zh) | 2014-11-05 | 2016-06-01 | 雷普特製藥有限公司 | 使用半胱胺組合物治療亨廷頓氏病之方法 |
| CA3017797A1 (en) | 2016-03-17 | 2017-09-21 | Thiogenesis Therapeutics, Inc. | Compositions for controlled release of cysteamine and systemic treatment of cysteamine sensitive disorders |
| WO2021022012A1 (en) | 2019-07-30 | 2021-02-04 | The Regents Of The University Of California | Methods and composition for treating respiratory obstructive diseases |
-
2020
- 2020-03-26 EP EP20778142.8A patent/EP3946298A4/en active Pending
- 2020-03-26 JP JP2021555221A patent/JP7538541B2/ja active Active
- 2020-03-26 CN CN202080024298.3A patent/CN113613642B/zh active Active
- 2020-03-26 WO PCT/US2020/025067 patent/WO2020198529A1/en not_active Ceased
- 2020-03-26 US US17/429,885 patent/US12391643B2/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2012503010A5 (enExample) | ||
| JP2010507585A5 (enExample) | ||
| JP2012524085A5 (enExample) | ||
| JP2009511481A5 (enExample) | ||
| ES2633658T3 (es) | Moduladores 2-oxo-1,2-dihidro-quinolina de la función inmunitaria | |
| US20240366591A1 (en) | Formulations and Pharmacokinetics of Deuterated Benzoquinoline Inhibitors of Vesicular Monoamine Transporter 2 | |
| JP2009538359A5 (enExample) | ||
| JP2009539863A5 (enExample) | ||
| US11191757B2 (en) | Combination of pimavanserin and cytochrome P450 modulators | |
| KR20160117596A (ko) | 신규 제약 제제 | |
| JP2022525148A5 (enExample) | ||
| JP2010512343A5 (enExample) | ||
| US10953000B2 (en) | Combination of pimavanserin and cytochrome P450 modulators | |
| JP2016529228A5 (enExample) | ||
| US20100247645A1 (en) | Pharmaceutical combination of aliskiren and valsartan | |
| CA2631581A1 (en) | Substituted phenethylamines with serotoninergic and/or norepinephrinergic activity | |
| JP2022529189A (ja) | 持続放出製剤 | |
| US9550780B2 (en) | Formulations pharmacokinetics of deuterated benzoquinoline inhibitors of vesicular monoamine transporter 2 | |
| JP4278652B2 (ja) | 結晶性シブトラミンメタンスルホン酸塩半水和物を含む医薬組成物 | |
| JP2018507210A5 (enExample) | ||
| JP2025509969A5 (enExample) | ||
| US7741334B2 (en) | Low dose therapy for treating viral infections | |
| JP2023507387A5 (enExample) | ||
| US20170182024A1 (en) | Pharmaceutical composition for the treatment of parkinson's disease | |
| RU2024129873A (ru) | Дейтерированные аналоги пиррольных ингибиторов erk, их синтез и промежуточные соединения |